Portal de Periódicos da CAPES

Recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas

2016; Elsevier BV; Volume: 52; Linguagem: Inglês

10.1016/s0300-2896(16)30198-3

1885-6195

Felipe Villar Álvarez, Ignacio Muguruza Trueba, José Belda Sanchis, Laureano Molins López-Rodó, Pedro Rodríguez, Julio Sánchez de Cos Escuín, Esther Barreiro, María Henar Borrego Pintado, Carlos Disdier Vicente, Javier Flandes Aldeyturriaga, Pablo Gámez García, Pilar Garrido, Pablo León Atance, José Miguel Izquierdo Elena, Nuria M. Novoa, Juan José Rivas de Andrés, Íñigo Royo Crespo, Ángel Salvatierra Velázquez, Luís M. Seijo Maceiras, Segismundo Solano Reina, Luís Bujanda, Régulo José Ávila Martínez, José Ignacio de Granda Orive, Eva de Higes Martínez, Vicente Díaz-Hellín Gude, Raúl Embún Flor, Jorge L. Freixinet Gilart, María Dolores García Jiménez, Fátima Hermoso Alarza, Samuel Sarmiento, Antonio Francisco Honguero Martínez, Carlos A. Jiménez Ruiz, Iker López Sanz, A. Mariscal, Primitivo Martínez Vallina, Patricia Menal Muñóz, Laura Mezquita Pérez, M.E. Olmedo García, Carlos A. Rombolá, I. San Miguel, María del Valle Somiedo Gutiérrez, Ana Isabel Triviño Ramírez, Joan Carles Trujillo Reyes, Carmen Vallejo, Paz Vaquero Lozano, Gonzálo Varela, Javier J. Zulueta,

Lung Cancer Research Studies

The Thoracic Surgery and Thoracic Oncology groups of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) have backed the publication of a handbook on recommendations for the diagnosis and treatment of non-small cell lung cancer. Due to the high incidence and mortality of this disease, the best scientific evidence must be constantly updated and made available for consultation by healthcare professionals. To draw up these recommendations, we called on a wide-ranging group of experts from the different specialties, who have prepared a comprehensive review, divided into 4 main sections. The first addresses disease prevention and screening, including risk factors, the role of smoking cessation, and screening programs for early diagnosis. The second section analyzes clinical presentation, imaging studies, and surgical risk, including cardiological risk and the evaluation of respiratory function. The third section addresses cytohistological confirmation and staging studies, and scrutinizes the TNM and histological classifications, non-invasive and minimally invasive sampling methods, and surgical techniques for diagnosis and staging. The fourth and final section looks at different therapeutic aspects, such as the role of surgery, chemotherapy, radiation therapy, a multidisciplinary approach according to disease stage, and other specifically targeted treatments, concluding with recommendations on the follow-up of lung cancer patients and surgical and endoscopic palliative interventions in advanced stages.